IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

August 31, 2014

Conditions
Hypertension
Interventions
DRUG

CCB use

Prescription of CCB during the study period between January 1, 1996 to December 31, 2009. The CCBs administered to the patients include isradipine and lacidipine.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01587742 - IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer | Biotech Hunter | Biotech Hunter